US Department of Energy — The DOE and NCI aims to develop next-generation supercomputing technology and accelerate cancer research to enable precision medicine.
STAT – Editing cells’ genomes with CRISPR-Cas9 might increase the risk that the altered cells, intended to treat disease, will trigger cancer, two studies published on Monday warn — a potential game-changer for the companies developing CRISPR-based therapies.
Los Angeles Times – In the all-hands effort to harness the powers of the immune system to fight cancer, scientists have reported a new approach that eliminated all evidence of advanced-stage breast cancer in a 49-year-old woman who had run out of treatment options.
CNN – About 70% of women diagnosed with the early stages of one of the most common forms of breast cancer might not need chemotherapy as part of treatment, according to the results of a long-awaited study.
The Guardian – Theresa May will pledge millions of pounds of government funding to develop artificial intelligence able to transform outcomes through early diagnosis of cancer and chronic disease.
The New York Times / The Associated Press – A court ruling that gave coffee drinkers a jolt earlier this year was finalized Monday when a Los Angeles judge said coffee sold in California must carry cancer warnings.
The Washington Post / The Associated Press – A Los Angeles judge ruled that California law requires coffee companies to carry an ominous cancer warning label because of a chemical produced in the roasting process.
Reuters – The US government said it will pay for certain genetic tests for Medicare-eligible patients with advanced cancer, in a bid to help match patients with the drugs most likely to provide benefit.
NPR – The FDA said it wants to sharply reduce the amount of nicotine in cigarettes. The idea is to help wean smokers off their deadly habit and prevent millions more from becoming regular smokers in the first place.
The Washington Post – The expected weeklong testimony is intended to help the federal judge determine whether a jury should hear from doctors who link the product to non-Hodgkin’s lymphoma.
Clinical OMICs – A team of scientists in the U.S. and China has created programmable DNA origami nanorobots that can seek out and shrink tumors by blocking their blood supply.